News

September 23, 2025

$5 million funds innovation of more-potent opioid overdose antidote

NIH funding aims to accelerate drug development timeline for enhanced version of naloxone.

News Release

March 5, 2025

Compound harnesses cannabis’ pain-relieving properties without side effects

Mouse study points to an effective alternative to opioids.

News Release

January 16, 2025

Drug in clinical trials for breast cancer could also treat some blood cancers

Researchers are working with industry toward a clinical trial for blood cancer patients.

News Release

October 23, 2024

Immunotherapy blocks scarring, improves heart function in mice with heart failure

Antibody that reduces inflammation could serve as cardio-immunotherapy for heart failure patients.

News Release

July 3, 2024

Experimental drug supercharges medicine that reverses opioid overdose

Adding newly ID’d compound makes naloxone more potent, longer lasting, mouse study shows.

News Release

January 16, 2024

Washington University and Deerfield Management launch VeritaScience to drive drug discovery

Deerfield Management makes 10-year commitment of up to $130 million to accelerate translation of Washington University discoveries to improve human health.

News Release

January 11, 2024

Awardees announced for Needleman innovation, commercialization program

DeSelm, DiPersio, Lavine receive support to advance promising therapeutics in cancer, heart disease.

Medical Campus & Community

October 18, 2023

Biotech industry leader to helm WashU drug development accelerator

Bhagwat leads program aimed at moving promising therapeutics into clinical trials .

News Release

August 4, 2023

Podcast: Newly approved drug may slow progression of Alzheimer’s

This episode of 'Show Me the Science' focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease.

Podcast, Show Me the Science

May 5, 2023

Needleman innovation program seeks proposals for therapeutic development

Up to $4 million in funding available to pursue ‘investigational new drug’ status.

Medical Campus & Community

May 3, 2023

Discovery suggests route to safer pain medications

Targeting opioid receptor pathway could treat pain without addiction, hallucinations.

News Release

February 9, 2023

Needlemans commit $15 million to boost drug discovery

Gift from longtime WashU benefactors to advance promising drug targets into early clinical trials .

News Release

November 30, 2022

WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive

Goal is to reduce dangerous side effects of potent opioid pain reliever.

News Release

September 7, 2022

Nasal COVID-19 vaccine approved in India based on Washington University technology

Inhaled vaccine may reduce infection, transmission.

News Release

November 18, 2021

Podcast: What’s up with boosters?

This episode of 'Show Me the Science' discusses the expanding availability of booster vaccines in the fight against COVID-19.

Podcast, Show Me the Science

November 11, 2021

Living with COVID-19

Science, medicine and healthcare adapt to a pandemic world.

Outlook Magazine

November 3, 2021

Podcast: Vaccines approved for younger kids

This episode of 'Show Me the Science' focuses on the newly announced federal emergency use authorization to vaccinate children ages 5 to 11. Millions of such children could be fully vaccinated by November's end.

Podcast, Show Me the Science

October 28, 2021

Inventive pathways: A research powerhouse becomes an innovation incubator

Turning research discoveries into real-world solutions can mean a decade of challenges. WashU is working to clear the way.

Outlook Magazine

October 11, 2021

Antiviral compound blocks SARS-CoV-2 from entering cells

New compound also could be effective against other coronaviruses.

News Release

July 8, 2021

New Alzheimer’s treatment targets identified

Study points to FDA-approved drugs that have potential to slow or reverse brain damage.

News Release

March 11, 2021

Combating COVID-19: Labs pivot to fight a common enemy

Labs retooled to investigate how the virus causes disease and to develop drugs, vaccines and diagnostics.

Outlook Magazine

March 7, 2021

Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant

Source: CBS News/60 Minutes

December 29, 2020

Podcast: Vaccines have arrived but COVID-19 treatments progressing much more slowly

This episode of 'Show Me the Science' contrasts the rapid development of effective vaccines with the lack of progress toward effective therapies.

Podcast, Show Me the Science